CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.
April 12th 2024
The novel CAR-T cell therapy, HR001, showed promise in a recent trial of patients with relapsed or refractory non-Hodgkin lymphoma.